The U.S. Food and Drug Administration’s decision this month to approve the narcotic painkiller OxyContin for use in children as young as 11 has raised a host of questions for parents, doctors and those who help treat addiction in juveniles.

Among them: Will the stamp of approval from the FDA lead to better research and pain relief for children, primarily cancer patients, suffering from […]